(Business Unit Performance Materials, Sales Support Team)
Gedung AIA Central, Level 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia
+62 21 2988 8557
Success! Your inquiry has been submitted to our Sales team.
Something went wrong! Please try after some time.
✓ Product has been added to quote
We have found 52 items.
| Requestor's contact details | |
| Full name | |
| Company | |
| Position | |
| Telephone number | |
| Work email address | |
| Shipping address | |
Thank you. Your request has been sent.
RACECADOTRIL is an antidiarrheal medication which acts as a peripheral enkephalinase inhibitor. RACECADOTRIL has an antisecretory effect - it reduces the secretion of water and electrolytes into the intestine.
Products still subject to third-party patent protection might be available solely for R&D purposes.
As a novel potassium-competitive acid blocker, VONOZOPRAN FUMARATE may provide reversible acid suppression by preventing K+ from binding to gastric H+/K+-ATPase. It has been clinically used for the short-term treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease and Helicobacter pylori (H. pylori) infection.
Products still subject to third-party patent protection might be available solely for R&D purposes.
MOSAPRIDE CITRATE is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist, which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans.
Products still subject to third-party patent protection might be available solely for R&D purposes.
RABEPRAZOLE SODIUM HYDRATE is a medication that decreases stomach acid. it is used to treat peptic ulcer disease, gastroesophageal reflux disease, and excess stomach acid production.
Products still subject to third-party patent protection might be available solely for R&D purposes.
